newsfilter
← Latest News
Business Wire·

Axcella Therapeutics to Participate in the SVB Leerink Global Healthcare Conference

Fireside chat to be webcast at 9:20 a.m. ET on February 17 Axcella Therapeutics (NASDAQ:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compos